CVnCoV Vaccine

CVnCoV Vaccine Uses, Dosage, Side Effects, Food Interaction and all others data.

The CVnCov Vaccine (or CV07050101) is in development by CureVac AG. The vaccine uses mRNA technology to create a protein associated with SARS-CoV2, and upon administration and replication, to initiate subsequent immune responses in the body. As of June 2020, the company received regulatory approval from German and Belgian Authorities to commence Phase 1 clinical trials of this vaccine (NCT04449276).

Trade Name CVnCoV Vaccine
Generic CVnCoV Vaccine
Type
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: September 19, 2023 at 7:00 am
CVnCoV Vaccine
CVnCoV Vaccine

Innovators Monograph

You find simplified version here CVnCoV Vaccine


*** Taking medicines without doctor's advice can cause long-term problems.
Share